Literature DB >> 28837809

Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States.

Jong Wook Kim1, Omar O Abudayyeh2, Huwate Yeerna3, Chen-Hsiang Yeang4, Michelle Stewart2, Russell W Jenkins5, Shunsuke Kitajima5, David J Konieczkowski6, Kate Medetgul-Ernar3, Taylor Cavazos3, Clarence Mah7, Stephanie Ting3, Eliezer M Van Allen8, Ofir Cohen8, John Mcdermott2, Emily Damato2, Andrew J Aguirre1, Jonathan Liang2, Arthur Liberzon2, Gabriella Alexe9, John Doench2, Mahmoud Ghandi2, Francisca Vazquez8, Barbara A Weir2, Aviad Tsherniak2, Aravind Subramanian2, Karina Meneses-Cime3, Jason Park3, Paul Clemons10, Levi A Garraway1, David Thomas2, Jesse S Boehm2, David A Barbie8, William C Hahn11, Jill P Mesirov12, Pablo Tamayo13.   

Abstract

The systematic sequencing of the cancer genome has led to the identification of numerous genetic alterations in cancer. However, a deeper understanding of the functional consequences of these alterations is necessary to guide appropriate therapeutic strategies. Here, we describe Onco-GPS (OncoGenic Positioning System), a data-driven analysis framework to organize individual tumor samples with shared oncogenic alterations onto a reference map defined by their underlying cellular states. We applied the methodology to the RAS pathway and identified nine distinct components that reflect transcriptional activities downstream of RAS and defined several functional states associated with patterns of transcriptional component activation that associates with genomic hallmarks and response to genetic and pharmacological perturbations. These results show that the Onco-GPS is an effective approach to explore the complex landscape of oncogenic cellular states across cancers, and an analytic framework to summarize knowledge, establish relationships, and generate more effective disease models for research or as part of individualized precision medicine paradigms.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bayesian nomogram; cellular states; drug sensitivity; genetic dependency; inferential model; matrix factorization; oncoGPS; oncogenic pathway; precision medicine; transcriptional signatures

Mesh:

Substances:

Year:  2017        PMID: 28837809      PMCID: PMC5639711          DOI: 10.1016/j.cels.2017.08.002

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  55 in total

1.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

2.  Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin.

Authors:  Kaede Hinata; Adam M Gervin; Y Jennifer Zhang; Paul A Khavari
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

3.  PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies.

Authors:  Thomas De Raedt; Eline Beert; Eric Pasmant; Armelle Luscan; Hilde Brems; Nicolas Ortonne; Kristian Helin; Jason L Hornick; Victor Mautner; Hildegard Kehrer-Sawatzki; Wade Clapp; James Bradner; Michel Vidaud; Meena Upadhyaya; Eric Legius; Karen Cichowski
Journal:  Nature       Date:  2014-08-13       Impact factor: 49.962

Review 4.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

5.  The Molecular Signatures Database (MSigDB) hallmark gene set collection.

Authors:  Arthur Liberzon; Chet Birger; Helga Thorvaldsdóttir; Mahmoud Ghandi; Jill P Mesirov; Pablo Tamayo
Journal:  Cell Syst       Date:  2015-12-23       Impact factor: 10.304

6.  MicroSCALE screening reveals genetic modifiers of therapeutic response in melanoma.

Authors:  Kris C Wood; David J Konieczkowski; Cory M Johannessen; Jesse S Boehm; Pablo Tamayo; Olga B Botvinnik; Jill P Mesirov; William C Hahn; David E Root; Levi A Garraway; David M Sabatini
Journal:  Sci Signal       Date:  2012-05-15       Impact factor: 8.192

7.  TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.

Authors:  Anurag Singh; Michael F Sweeney; Min Yu; Alexa Burger; Patricia Greninger; Cyril Benes; Daniel A Haber; Jeff Settleman
Journal:  Cell       Date:  2012-02-17       Impact factor: 41.582

8.  A method for high-throughput gene expression signature analysis.

Authors:  David Peck; Emily D Crawford; Kenneth N Ross; Kimberly Stegmaier; Todd R Golub; Justin Lamb
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

9.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.

Authors:  Wanjuan Yang; Jorge Soares; Patricia Greninger; Elena J Edelman; Howard Lightfoot; Simon Forbes; Nidhi Bindal; Dave Beare; James A Smith; I Richard Thompson; Sridhar Ramaswamy; P Andrew Futreal; Daniel A Haber; Michael R Stratton; Cyril Benes; Ultan McDermott; Mathew J Garnett
Journal:  Nucleic Acids Res       Date:  2012-11-23       Impact factor: 16.971

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  17 in total

1.  Computational Analyses Connect Small-Molecule Sensitivity to Cellular Features Using Large Panels of Cancer Cell Lines.

Authors:  Matthew G Rees; Brinton Seashore-Ludlow; Paul A Clemons
Journal:  Methods Mol Biol       Date:  2019

2.  Tissue- and development-stage-specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples.

Authors:  Anshuman Panda; Anupama Yadav; Huwate Yeerna; Amartya Singh; Michael Biehl; Markus Lux; Alexander Schulz; Tyler Klecha; Sebastian Doniach; Hossein Khiabanian; Shridar Ganesan; Pablo Tamayo; Gyan Bhanot
Journal:  Nucleic Acids Res       Date:  2020-07-27       Impact factor: 16.971

3.  Decomposing Cell Identity for Transfer Learning across Cellular Measurements, Platforms, Tissues, and Species.

Authors:  Genevieve L Stein-O'Brien; Brian S Clark; Thomas Sherman; Cristina Zibetti; Qiwen Hu; Rachel Sealfon; Sheng Liu; Jiang Qian; Carlo Colantuoni; Seth Blackshaw; Loyal A Goff; Elana J Fertig
Journal:  Cell Syst       Date:  2019-05-22       Impact factor: 10.304

4.  Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.

Authors:  Pablo Tamayo; Thomas R Cech; Franklin W Huang; Josh Lewis Stern; Grace Hibshman; Kevin Hu; Sarah E Ferrara; James C Costello; William Kim
Journal:  Mol Cancer Res       Date:  2020-04-10       Impact factor: 5.852

5.  Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.

Authors:  Chao Liu; Sayed H Sadat; Koji Ebisumoto; Akihiro Sakai; Bharat A Panuganti; Shuling Ren; Yusuke Goto; Sunny Haft; Takahito Fukusumi; Mizuo Ando; Yuki Saito; Theresa Guo; Pablo Tamayo; Huwate Yeerna; William Kim; Jacqueline Hubbard; Andrew B Sharabi; J Silvio Gutkind; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2020-01-13       Impact factor: 12.531

6.  Visualizing and Interpreting Single-Cell Gene Expression Datasets with Similarity Weighted Nonnegative Embedding.

Authors:  Yan Wu; Pablo Tamayo; Kun Zhang
Journal:  Cell Syst       Date:  2018-12-05       Impact factor: 10.304

7.  KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor.

Authors:  Sudeep Banerjee; Hyunho Yoon; Stephanie Ting; Chih-Min Tang; Mayra Yebra; Alexander T Wenzel; Huwate Yeerna; Jill P Mesirov; Robert J Wechsler-Reya; Pablo Tamayo; Jason K Sicklick
Journal:  Mol Cancer Ther       Date:  2021-08-10       Impact factor: 6.261

8.  Systematic Evaluation of Molecular Networks for Discovery of Disease Genes.

Authors:  Justin K Huang; Daniel E Carlin; Michael Ku Yu; Wei Zhang; Jason F Kreisberg; Pablo Tamayo; Trey Ideker
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

9.  DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes.

Authors:  Brian Reilly; Tiffany N Tanaka; Dinh Diep; Huwate Yeerna; Pablo Tamayo; Kun Zhang; Rafael Bejar
Journal:  Blood Adv       Date:  2019-10-08

Review 10.  An expanded universe of cancer targets.

Authors:  William C Hahn; Joel S Bader; Theodore P Braun; Andrea Califano; Paul A Clemons; Brian J Druker; Andrew J Ewald; Haian Fu; Subhashini Jagu; Christopher J Kemp; William Kim; Calvin J Kuo; Michael McManus; Gordon B Mills; Xiulei Mo; Nidhi Sahni; Stuart L Schreiber; Jessica A Talamas; Pablo Tamayo; Jeffrey W Tyner; Bridget K Wagner; William A Weiss; Daniela S Gerhard
Journal:  Cell       Date:  2021-03-04       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.